nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—CHRM3—ureter—prostate cancer	0.0976	0.625	CbGeAlD
Propantheline—CHRM2—prostate gland—prostate cancer	0.014	0.0895	CbGeAlD
Propantheline—CHRM1—prostate gland—prostate cancer	0.0127	0.0815	CbGeAlD
Propantheline—CHRM3—prostate gland—prostate cancer	0.0114	0.0729	CbGeAlD
Propantheline—CHRM3—renal system—prostate cancer	0.00776	0.0497	CbGeAlD
Propantheline—CHRM3—urethra—prostate cancer	0.00763	0.0488	CbGeAlD
Propantheline—CHRM3—testis—prostate cancer	0.00502	0.0321	CbGeAlD
Propantheline—Dermatitis—Flutamide—prostate cancer	0.0025	0.00369	CcSEcCtD
Propantheline—Headache—Nilutamide—prostate cancer	0.0025	0.00368	CcSEcCtD
Propantheline—Headache—Flutamide—prostate cancer	0.00249	0.00367	CcSEcCtD
Propantheline—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00248	0.00365	CcSEcCtD
Propantheline—Hypersensitivity—Cabazitaxel—prostate cancer	0.00248	0.00365	CcSEcCtD
Propantheline—Constipation—Bicalutamide—prostate cancer	0.00247	0.00363	CcSEcCtD
Propantheline—Dermatitis atopic—Doxorubicin—prostate cancer	0.00242	0.00356	CcSEcCtD
Propantheline—Tension—Goserelin—prostate cancer	0.00241	0.00355	CcSEcCtD
Propantheline—Asthenia—Cabazitaxel—prostate cancer	0.00241	0.00355	CcSEcCtD
Propantheline—Erectile dysfunction—Mitoxantrone—prostate cancer	0.0024	0.00353	CcSEcCtD
Propantheline—Tension—Conjugated Estrogens—prostate cancer	0.00239	0.00352	CcSEcCtD
Propantheline—Nervousness—Goserelin—prostate cancer	0.00239	0.00352	CcSEcCtD
Propantheline—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00239	0.00351	CcSEcCtD
Propantheline—Feeling abnormal—Bicalutamide—prostate cancer	0.00238	0.0035	CcSEcCtD
Propantheline—Nausea—Nilutamide—prostate cancer	0.00237	0.00349	CcSEcCtD
Propantheline—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00237	0.00348	CcSEcCtD
Propantheline—Nervousness—Conjugated Estrogens—prostate cancer	0.00236	0.00348	CcSEcCtD
Propantheline—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00236	0.00348	CcSEcCtD
Propantheline—Nausea—Flutamide—prostate cancer	0.00236	0.00348	CcSEcCtD
Propantheline—Dizziness—Degarelix—prostate cancer	0.00236	0.00347	CcSEcCtD
Propantheline—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00235	0.00346	CcSEcCtD
Propantheline—Drowsiness—Mitoxantrone—prostate cancer	0.00232	0.00342	CcSEcCtD
Propantheline—Vision blurred—Goserelin—prostate cancer	0.00232	0.00341	CcSEcCtD
Propantheline—Vision blurred—Conjugated Estrogens—prostate cancer	0.00229	0.00338	CcSEcCtD
Propantheline—Urticaria—Bicalutamide—prostate cancer	0.00229	0.00337	CcSEcCtD
Propantheline—Vomiting—Degarelix—prostate cancer	0.00227	0.00334	CcSEcCtD
Propantheline—Rash—Degarelix—prostate cancer	0.00225	0.00331	CcSEcCtD
Propantheline—Dermatitis—Degarelix—prostate cancer	0.00225	0.00331	CcSEcCtD
Propantheline—Headache—Degarelix—prostate cancer	0.00223	0.00329	CcSEcCtD
Propantheline—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00223	0.00328	CcSEcCtD
Propantheline—Dizziness—Cabazitaxel—prostate cancer	0.00222	0.00327	CcSEcCtD
Propantheline—Palpitations—Goserelin—prostate cancer	0.00217	0.0032	CcSEcCtD
Propantheline—Dysphagia—Etoposide—prostate cancer	0.00217	0.00319	CcSEcCtD
Propantheline—Palpitations—Conjugated Estrogens—prostate cancer	0.00215	0.00317	CcSEcCtD
Propantheline—Vomiting—Cabazitaxel—prostate cancer	0.00214	0.00315	CcSEcCtD
Propantheline—Hypersensitivity—Bicalutamide—prostate cancer	0.00212	0.00313	CcSEcCtD
Propantheline—Thirst—Capecitabine—prostate cancer	0.00212	0.00312	CcSEcCtD
Propantheline—Nausea—Degarelix—prostate cancer	0.00212	0.00312	CcSEcCtD
Propantheline—Headache—Cabazitaxel—prostate cancer	0.00211	0.0031	CcSEcCtD
Propantheline—Constipation—Ethinyl Estradiol—prostate cancer	0.00208	0.00307	CcSEcCtD
Propantheline—Flushing—Estradiol—prostate cancer	0.00208	0.00306	CcSEcCtD
Propantheline—Asthenia—Bicalutamide—prostate cancer	0.00207	0.00305	CcSEcCtD
Propantheline—Dry mouth—Goserelin—prostate cancer	0.00205	0.00301	CcSEcCtD
Propantheline—Confusional state—Goserelin—prostate cancer	0.00202	0.00298	CcSEcCtD
Propantheline—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.00201	0.00296	CcSEcCtD
Propantheline—Anaphylactic shock—Goserelin—prostate cancer	0.00201	0.00295	CcSEcCtD
Propantheline—Nausea—Cabazitaxel—prostate cancer	0.002	0.00294	CcSEcCtD
Propantheline—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00199	0.00293	CcSEcCtD
Propantheline—Tachycardia—Goserelin—prostate cancer	0.00196	0.00288	CcSEcCtD
Propantheline—Tachycardia—Conjugated Estrogens—prostate cancer	0.00194	0.00286	CcSEcCtD
Propantheline—Urticaria—Ethinyl Estradiol—prostate cancer	0.00194	0.00285	CcSEcCtD
Propantheline—Tension—Estradiol—prostate cancer	0.00191	0.00282	CcSEcCtD
Propantheline—Dizziness—Bicalutamide—prostate cancer	0.00191	0.00281	CcSEcCtD
Propantheline—Nervousness—Estradiol—prostate cancer	0.00189	0.00279	CcSEcCtD
Propantheline—Salivary hypersecretion—Epirubicin—prostate cancer	0.00188	0.00277	CcSEcCtD
Propantheline—Vomiting—Bicalutamide—prostate cancer	0.00183	0.0027	CcSEcCtD
Propantheline—Rash—Bicalutamide—prostate cancer	0.00182	0.00268	CcSEcCtD
Propantheline—Dermatitis—Bicalutamide—prostate cancer	0.00182	0.00267	CcSEcCtD
Propantheline—Insomnia—Goserelin—prostate cancer	0.00181	0.00267	CcSEcCtD
Propantheline—Headache—Bicalutamide—prostate cancer	0.00181	0.00266	CcSEcCtD
Propantheline—Dysphagia—Docetaxel—prostate cancer	0.0018	0.00265	CcSEcCtD
Propantheline—Insomnia—Conjugated Estrogens—prostate cancer	0.0018	0.00265	CcSEcCtD
Propantheline—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.0018	0.00264	CcSEcCtD
Propantheline—Somnolence—Goserelin—prostate cancer	0.00178	0.00263	CcSEcCtD
Propantheline—Somnolence—Conjugated Estrogens—prostate cancer	0.00177	0.0026	CcSEcCtD
Propantheline—Abdominal distension—Capecitabine—prostate cancer	0.00176	0.00259	CcSEcCtD
Propantheline—Asthenia—Ethinyl Estradiol—prostate cancer	0.00175	0.00258	CcSEcCtD
Propantheline—Dysphagia—Capecitabine—prostate cancer	0.00174	0.00257	CcSEcCtD
Propantheline—Salivary hypersecretion—Doxorubicin—prostate cancer	0.00174	0.00256	CcSEcCtD
Propantheline—Palpitations—Estradiol—prostate cancer	0.00172	0.00254	CcSEcCtD
Propantheline—Constipation—Goserelin—prostate cancer	0.00171	0.00253	CcSEcCtD
Propantheline—Nausea—Bicalutamide—prostate cancer	0.00171	0.00252	CcSEcCtD
Propantheline—Vision blurred—Mitoxantrone—prostate cancer	0.00171	0.00252	CcSEcCtD
Propantheline—Constipation—Conjugated Estrogens—prostate cancer	0.0017	0.0025	CcSEcCtD
Propantheline—Feeling abnormal—Goserelin—prostate cancer	0.00165	0.00243	CcSEcCtD
Propantheline—Dry mouth—Estradiol—prostate cancer	0.00162	0.00239	CcSEcCtD
Propantheline—Dizziness—Ethinyl Estradiol—prostate cancer	0.00161	0.00237	CcSEcCtD
Propantheline—Flushing—Etoposide—prostate cancer	0.00161	0.00237	CcSEcCtD
Propantheline—Confusional state—Estradiol—prostate cancer	0.0016	0.00236	CcSEcCtD
Propantheline—Urticaria—Goserelin—prostate cancer	0.00159	0.00235	CcSEcCtD
Propantheline—Anaphylactic shock—Estradiol—prostate cancer	0.00159	0.00234	CcSEcCtD
Propantheline—Urticaria—Conjugated Estrogens—prostate cancer	0.00158	0.00232	CcSEcCtD
Propantheline—Abdominal distension—Prednisone—prostate cancer	0.00156	0.0023	CcSEcCtD
Propantheline—Tachycardia—Estradiol—prostate cancer	0.00155	0.00229	CcSEcCtD
Propantheline—Vomiting—Ethinyl Estradiol—prostate cancer	0.00155	0.00228	CcSEcCtD
Propantheline—Rash—Ethinyl Estradiol—prostate cancer	0.00154	0.00226	CcSEcCtD
Propantheline—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00153	0.00226	CcSEcCtD
Propantheline—Headache—Ethinyl Estradiol—prostate cancer	0.00153	0.00225	CcSEcCtD
Propantheline—Confusional state—Mitoxantrone—prostate cancer	0.00149	0.0022	CcSEcCtD
Propantheline—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00148	0.00218	CcSEcCtD
Propantheline—Hypersensitivity—Goserelin—prostate cancer	0.00148	0.00218	CcSEcCtD
Propantheline—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00146	0.00216	CcSEcCtD
Propantheline—Nausea—Ethinyl Estradiol—prostate cancer	0.00145	0.00213	CcSEcCtD
Propantheline—Tachycardia—Mitoxantrone—prostate cancer	0.00145	0.00213	CcSEcCtD
Propantheline—Asthenia—Goserelin—prostate cancer	0.00144	0.00212	CcSEcCtD
Propantheline—Insomnia—Estradiol—prostate cancer	0.00144	0.00212	CcSEcCtD
Propantheline—Erectile dysfunction—Prednisone—prostate cancer	0.00143	0.00211	CcSEcCtD
Propantheline—Asthenia—Conjugated Estrogens—prostate cancer	0.00143	0.0021	CcSEcCtD
Propantheline—Somnolence—Estradiol—prostate cancer	0.00141	0.00208	CcSEcCtD
Propantheline—Constipation—Estradiol—prostate cancer	0.00136	0.002	CcSEcCtD
Propantheline—Flushing—Docetaxel—prostate cancer	0.00134	0.00197	CcSEcCtD
Propantheline—Dizziness—Goserelin—prostate cancer	0.00133	0.00195	CcSEcCtD
Propantheline—Somnolence—Mitoxantrone—prostate cancer	0.00132	0.00194	CcSEcCtD
Propantheline—Dizziness—Conjugated Estrogens—prostate cancer	0.00131	0.00193	CcSEcCtD
Propantheline—Feeling abnormal—Estradiol—prostate cancer	0.00131	0.00193	CcSEcCtD
Propantheline—Flushing—Capecitabine—prostate cancer	0.0013	0.00191	CcSEcCtD
Propantheline—Vomiting—Goserelin—prostate cancer	0.00128	0.00188	CcSEcCtD
Propantheline—Constipation—Mitoxantrone—prostate cancer	0.00127	0.00187	CcSEcCtD
Propantheline—Rash—Goserelin—prostate cancer	0.00126	0.00186	CcSEcCtD
Propantheline—Dermatitis—Goserelin—prostate cancer	0.00126	0.00186	CcSEcCtD
Propantheline—Vomiting—Conjugated Estrogens—prostate cancer	0.00126	0.00186	CcSEcCtD
Propantheline—Urticaria—Estradiol—prostate cancer	0.00126	0.00186	CcSEcCtD
Propantheline—Headache—Goserelin—prostate cancer	0.00126	0.00185	CcSEcCtD
Propantheline—Rash—Conjugated Estrogens—prostate cancer	0.00125	0.00184	CcSEcCtD
Propantheline—Dermatitis—Conjugated Estrogens—prostate cancer	0.00125	0.00184	CcSEcCtD
Propantheline—Headache—Conjugated Estrogens—prostate cancer	0.00124	0.00183	CcSEcCtD
Propantheline—Confusional state—Etoposide—prostate cancer	0.00124	0.00183	CcSEcCtD
Propantheline—Anaphylactic shock—Etoposide—prostate cancer	0.00123	0.00181	CcSEcCtD
Propantheline—Abdominal distension—Epirubicin—prostate cancer	0.00122	0.0018	CcSEcCtD
Propantheline—Feeling abnormal—Mitoxantrone—prostate cancer	0.00122	0.0018	CcSEcCtD
Propantheline—Dysphagia—Epirubicin—prostate cancer	0.00121	0.00179	CcSEcCtD
Propantheline—Tachycardia—Etoposide—prostate cancer	0.0012	0.00177	CcSEcCtD
Propantheline—Nausea—Goserelin—prostate cancer	0.00119	0.00175	CcSEcCtD
Propantheline—Nausea—Conjugated Estrogens—prostate cancer	0.00118	0.00174	CcSEcCtD
Propantheline—Urticaria—Mitoxantrone—prostate cancer	0.00118	0.00173	CcSEcCtD
Propantheline—Hypersensitivity—Estradiol—prostate cancer	0.00117	0.00173	CcSEcCtD
Propantheline—Flushing—Prednisone—prostate cancer	0.00115	0.0017	CcSEcCtD
Propantheline—Vision blurred—Capecitabine—prostate cancer	0.00114	0.00169	CcSEcCtD
Propantheline—Asthenia—Estradiol—prostate cancer	0.00114	0.00168	CcSEcCtD
Propantheline—Abdominal distension—Doxorubicin—prostate cancer	0.00113	0.00167	CcSEcCtD
Propantheline—Dysphagia—Doxorubicin—prostate cancer	0.00112	0.00166	CcSEcCtD
Propantheline—Palpitations—Docetaxel—prostate cancer	0.00111	0.00163	CcSEcCtD
Propantheline—Somnolence—Etoposide—prostate cancer	0.0011	0.00161	CcSEcCtD
Propantheline—Hypersensitivity—Mitoxantrone—prostate cancer	0.00109	0.00161	CcSEcCtD
Propantheline—Drowsiness—Epirubicin—prostate cancer	0.00108	0.0016	CcSEcCtD
Propantheline—Palpitations—Capecitabine—prostate cancer	0.00107	0.00158	CcSEcCtD
Propantheline—Asthenia—Mitoxantrone—prostate cancer	0.00106	0.00157	CcSEcCtD
Propantheline—Constipation—Etoposide—prostate cancer	0.00105	0.00155	CcSEcCtD
Propantheline—Dizziness—Estradiol—prostate cancer	0.00105	0.00155	CcSEcCtD
Propantheline—Dry mouth—Docetaxel—prostate cancer	0.00104	0.00154	CcSEcCtD
Propantheline—Confusional state—Docetaxel—prostate cancer	0.00103	0.00152	CcSEcCtD
Propantheline—Anaphylactic shock—Docetaxel—prostate cancer	0.00102	0.00151	CcSEcCtD
Propantheline—Vision blurred—Prednisone—prostate cancer	0.00102	0.0015	CcSEcCtD
Propantheline—Feeling abnormal—Etoposide—prostate cancer	0.00102	0.0015	CcSEcCtD
Propantheline—Dry mouth—Capecitabine—prostate cancer	0.00101	0.00149	CcSEcCtD
Propantheline—Vomiting—Estradiol—prostate cancer	0.00101	0.00149	CcSEcCtD
Propantheline—Rash—Estradiol—prostate cancer	0.001	0.00148	CcSEcCtD
Propantheline—Drowsiness—Doxorubicin—prostate cancer	0.001	0.00148	CcSEcCtD
Propantheline—Dermatitis—Estradiol—prostate cancer	0.001	0.00148	CcSEcCtD
Propantheline—Confusional state—Capecitabine—prostate cancer	0.001	0.00147	CcSEcCtD
Propantheline—Tachycardia—Docetaxel—prostate cancer	0.000999	0.00147	CcSEcCtD
Propantheline—Headache—Estradiol—prostate cancer	0.000996	0.00147	CcSEcCtD
Propantheline—Urticaria—Etoposide—prostate cancer	0.000979	0.00144	CcSEcCtD
Propantheline—Tachycardia—Capecitabine—prostate cancer	0.000968	0.00143	CcSEcCtD
Propantheline—Nausea—Estradiol—prostate cancer	0.000944	0.00139	CcSEcCtD
Propantheline—Vomiting—Mitoxantrone—prostate cancer	0.000942	0.00139	CcSEcCtD
Propantheline—Rash—Mitoxantrone—prostate cancer	0.000934	0.00138	CcSEcCtD
Propantheline—Dermatitis—Mitoxantrone—prostate cancer	0.000933	0.00137	CcSEcCtD
Propantheline—Headache—Mitoxantrone—prostate cancer	0.000928	0.00137	CcSEcCtD
Propantheline—Insomnia—Docetaxel—prostate cancer	0.000926	0.00136	CcSEcCtD
Propantheline—Somnolence—Docetaxel—prostate cancer	0.00091	0.00134	CcSEcCtD
Propantheline—Hypersensitivity—Etoposide—prostate cancer	0.000908	0.00134	CcSEcCtD
Propantheline—Flushing—Epirubicin—prostate cancer	0.000902	0.00133	CcSEcCtD
Propantheline—Insomnia—Capecitabine—prostate cancer	0.000897	0.00132	CcSEcCtD
Propantheline—Asthenia—Etoposide—prostate cancer	0.000884	0.0013	CcSEcCtD
Propantheline—Anaphylactic shock—Prednisone—prostate cancer	0.000883	0.0013	CcSEcCtD
Propantheline—Nausea—Mitoxantrone—prostate cancer	0.00088	0.0013	CcSEcCtD
Propantheline—Constipation—Docetaxel—prostate cancer	0.000876	0.00129	CcSEcCtD
Propantheline—Tachycardia—Prednisone—prostate cancer	0.000862	0.00127	CcSEcCtD
Propantheline—Constipation—Capecitabine—prostate cancer	0.000848	0.00125	CcSEcCtD
Propantheline—Feeling abnormal—Docetaxel—prostate cancer	0.000844	0.00124	CcSEcCtD
Propantheline—Flushing—Doxorubicin—prostate cancer	0.000835	0.00123	CcSEcCtD
Propantheline—Tension—Epirubicin—prostate cancer	0.00083	0.00122	CcSEcCtD
Propantheline—Nervousness—Epirubicin—prostate cancer	0.000822	0.00121	CcSEcCtD
Propantheline—Feeling abnormal—Capecitabine—prostate cancer	0.000817	0.0012	CcSEcCtD
Propantheline—Dizziness—Etoposide—prostate cancer	0.000815	0.0012	CcSEcCtD
Propantheline—Insomnia—Prednisone—prostate cancer	0.000799	0.00118	CcSEcCtD
Propantheline—Vision blurred—Epirubicin—prostate cancer	0.000798	0.00117	CcSEcCtD
Propantheline—Urticaria—Capecitabine—prostate cancer	0.000788	0.00116	CcSEcCtD
Propantheline—Vomiting—Etoposide—prostate cancer	0.000783	0.00115	CcSEcCtD
Propantheline—Rash—Etoposide—prostate cancer	0.000777	0.00114	CcSEcCtD
Propantheline—Dermatitis—Etoposide—prostate cancer	0.000776	0.00114	CcSEcCtD
Propantheline—Headache—Etoposide—prostate cancer	0.000772	0.00114	CcSEcCtD
Propantheline—Tension—Doxorubicin—prostate cancer	0.000768	0.00113	CcSEcCtD
Propantheline—Nervousness—Doxorubicin—prostate cancer	0.00076	0.00112	CcSEcCtD
Propantheline—Constipation—Prednisone—prostate cancer	0.000755	0.00111	CcSEcCtD
Propantheline—Hypersensitivity—Docetaxel—prostate cancer	0.000754	0.00111	CcSEcCtD
Propantheline—Palpitations—Epirubicin—prostate cancer	0.000748	0.0011	CcSEcCtD
Propantheline—Vision blurred—Doxorubicin—prostate cancer	0.000738	0.00109	CcSEcCtD
Propantheline—Asthenia—Docetaxel—prostate cancer	0.000735	0.00108	CcSEcCtD
Propantheline—Nausea—Etoposide—prostate cancer	0.000732	0.00108	CcSEcCtD
Propantheline—Hypersensitivity—Capecitabine—prostate cancer	0.00073	0.00108	CcSEcCtD
Propantheline—Feeling abnormal—Prednisone—prostate cancer	0.000728	0.00107	CcSEcCtD
Propantheline—Asthenia—Capecitabine—prostate cancer	0.000711	0.00105	CcSEcCtD
Propantheline—Dry mouth—Epirubicin—prostate cancer	0.000705	0.00104	CcSEcCtD
Propantheline—Urticaria—Prednisone—prostate cancer	0.000702	0.00103	CcSEcCtD
Propantheline—Confusional state—Epirubicin—prostate cancer	0.000696	0.00103	CcSEcCtD
Propantheline—Palpitations—Doxorubicin—prostate cancer	0.000692	0.00102	CcSEcCtD
Propantheline—Anaphylactic shock—Epirubicin—prostate cancer	0.000691	0.00102	CcSEcCtD
Propantheline—Dizziness—Docetaxel—prostate cancer	0.000677	0.000997	CcSEcCtD
Propantheline—Tachycardia—Epirubicin—prostate cancer	0.000674	0.000993	CcSEcCtD
Propantheline—Dizziness—Capecitabine—prostate cancer	0.000656	0.000966	CcSEcCtD
Propantheline—Dry mouth—Doxorubicin—prostate cancer	0.000652	0.00096	CcSEcCtD
Propantheline—Vomiting—Docetaxel—prostate cancer	0.000651	0.000959	CcSEcCtD
Propantheline—Hypersensitivity—Prednisone—prostate cancer	0.000651	0.000958	CcSEcCtD
Propantheline—Rash—Docetaxel—prostate cancer	0.000646	0.000951	CcSEcCtD
Propantheline—Dermatitis—Docetaxel—prostate cancer	0.000645	0.00095	CcSEcCtD
Propantheline—Confusional state—Doxorubicin—prostate cancer	0.000644	0.000949	CcSEcCtD
Propantheline—Headache—Docetaxel—prostate cancer	0.000641	0.000945	CcSEcCtD
Propantheline—Anaphylactic shock—Doxorubicin—prostate cancer	0.000639	0.000941	CcSEcCtD
Propantheline—Asthenia—Prednisone—prostate cancer	0.000634	0.000933	CcSEcCtD
Propantheline—Vomiting—Capecitabine—prostate cancer	0.00063	0.000929	CcSEcCtD
Propantheline—Rash—Capecitabine—prostate cancer	0.000625	0.000921	CcSEcCtD
Propantheline—Insomnia—Epirubicin—prostate cancer	0.000625	0.00092	CcSEcCtD
Propantheline—Dermatitis—Capecitabine—prostate cancer	0.000624	0.00092	CcSEcCtD
Propantheline—Tachycardia—Doxorubicin—prostate cancer	0.000624	0.000919	CcSEcCtD
Propantheline—Headache—Capecitabine—prostate cancer	0.000621	0.000915	CcSEcCtD
Propantheline—Somnolence—Epirubicin—prostate cancer	0.000614	0.000904	CcSEcCtD
Propantheline—Nausea—Docetaxel—prostate cancer	0.000608	0.000896	CcSEcCtD
Propantheline—Constipation—Epirubicin—prostate cancer	0.000591	0.00087	CcSEcCtD
Propantheline—Nausea—Capecitabine—prostate cancer	0.000589	0.000867	CcSEcCtD
Propantheline—Dizziness—Prednisone—prostate cancer	0.000584	0.00086	CcSEcCtD
Propantheline—Insomnia—Doxorubicin—prostate cancer	0.000578	0.000851	CcSEcCtD
Propantheline—Feeling abnormal—Epirubicin—prostate cancer	0.000569	0.000838	CcSEcCtD
Propantheline—Somnolence—Doxorubicin—prostate cancer	0.000568	0.000837	CcSEcCtD
Propantheline—Vomiting—Prednisone—prostate cancer	0.000561	0.000827	CcSEcCtD
Propantheline—Rash—Prednisone—prostate cancer	0.000557	0.00082	CcSEcCtD
Propantheline—Dermatitis—Prednisone—prostate cancer	0.000556	0.000819	CcSEcCtD
Propantheline—Headache—Prednisone—prostate cancer	0.000553	0.000815	CcSEcCtD
Propantheline—Urticaria—Epirubicin—prostate cancer	0.000549	0.000808	CcSEcCtD
Propantheline—Constipation—Doxorubicin—prostate cancer	0.000546	0.000805	CcSEcCtD
Propantheline—Feeling abnormal—Doxorubicin—prostate cancer	0.000527	0.000776	CcSEcCtD
Propantheline—Nausea—Prednisone—prostate cancer	0.000525	0.000773	CcSEcCtD
Propantheline—Hypersensitivity—Epirubicin—prostate cancer	0.000509	0.00075	CcSEcCtD
Propantheline—Urticaria—Doxorubicin—prostate cancer	0.000508	0.000748	CcSEcCtD
Propantheline—Asthenia—Epirubicin—prostate cancer	0.000496	0.00073	CcSEcCtD
Propantheline—Hypersensitivity—Doxorubicin—prostate cancer	0.000471	0.000694	CcSEcCtD
Propantheline—Asthenia—Doxorubicin—prostate cancer	0.000458	0.000675	CcSEcCtD
Propantheline—Dizziness—Epirubicin—prostate cancer	0.000457	0.000673	CcSEcCtD
Propantheline—Vomiting—Epirubicin—prostate cancer	0.000439	0.000647	CcSEcCtD
Propantheline—Rash—Epirubicin—prostate cancer	0.000435	0.000641	CcSEcCtD
Propantheline—Dermatitis—Epirubicin—prostate cancer	0.000435	0.000641	CcSEcCtD
Propantheline—Headache—Epirubicin—prostate cancer	0.000433	0.000637	CcSEcCtD
Propantheline—Dizziness—Doxorubicin—prostate cancer	0.000423	0.000622	CcSEcCtD
Propantheline—Nausea—Epirubicin—prostate cancer	0.00041	0.000604	CcSEcCtD
Propantheline—Vomiting—Doxorubicin—prostate cancer	0.000406	0.000599	CcSEcCtD
Propantheline—Rash—Doxorubicin—prostate cancer	0.000403	0.000594	CcSEcCtD
Propantheline—Dermatitis—Doxorubicin—prostate cancer	0.000403	0.000593	CcSEcCtD
Propantheline—Headache—Doxorubicin—prostate cancer	0.0004	0.00059	CcSEcCtD
Propantheline—Nausea—Doxorubicin—prostate cancer	0.00038	0.000559	CcSEcCtD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CD—prostate cancer	4.61e-05	0.00028	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CD—prostate cancer	4.6e-05	0.000279	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—TYMS—prostate cancer	4.57e-05	0.000277	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCQ—prostate cancer	4.56e-05	0.000277	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NGFR—prostate cancer	4.56e-05	0.000277	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	4.55e-05	0.000276	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NGFR—prostate cancer	4.55e-05	0.000276	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCQ—prostate cancer	4.55e-05	0.000276	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GSTM1—prostate cancer	4.52e-05	0.000274	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAP3K7—prostate cancer	4.51e-05	0.000273	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	4.51e-05	0.000273	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NGFR—prostate cancer	4.51e-05	0.000273	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAP3K7—prostate cancer	4.5e-05	0.000273	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	4.45e-05	0.00027	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—LPL—prostate cancer	4.44e-05	0.000269	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF10—prostate cancer	4.34e-05	0.000263	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF10—prostate cancer	4.32e-05	0.000262	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADRB2—prostate cancer	4.29e-05	0.00026	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CYP1A1—prostate cancer	4.28e-05	0.00026	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF10—prostate cancer	4.28e-05	0.00026	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADRB2—prostate cancer	4.28e-05	0.000259	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ERCC2—prostate cancer	4.25e-05	0.000258	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADRB2—prostate cancer	4.24e-05	0.000257	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—JAK2—prostate cancer	4.23e-05	0.000257	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—JAK2—prostate cancer	4.22e-05	0.000256	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—MAP2K1—prostate cancer	4.22e-05	0.000256	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—MAP2K1—prostate cancer	4.2e-05	0.000255	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CD—prostate cancer	4.19e-05	0.000254	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VAV3—prostate cancer	4.18e-05	0.000254	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	4.18e-05	0.000253	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CD—prostate cancer	4.18e-05	0.000253	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VAV3—prostate cancer	4.17e-05	0.000253	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	4.16e-05	0.000252	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	4.13e-05	0.000251	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VAV3—prostate cancer	4.13e-05	0.00025	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFBR2—prostate cancer	4.13e-05	0.00025	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFBR2—prostate cancer	4.11e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	4.07e-05	0.000247	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ITPR1—prostate cancer	4.06e-05	0.000246	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ITPR1—prostate cancer	4.05e-05	0.000245	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CB—prostate cancer	4.02e-05	0.000244	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CB—prostate cancer	4.01e-05	0.000243	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ITPR1—prostate cancer	4.01e-05	0.000243	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—MTHFR—prostate cancer	3.99e-05	0.000242	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	3.97e-05	0.000241	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARA—prostate cancer	3.92e-05	0.000238	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1R—prostate cancer	3.88e-05	0.000235	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1R—prostate cancer	3.87e-05	0.000235	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CXCL8—prostate cancer	3.86e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CXCL8—prostate cancer	3.85e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—JAK2—prostate cancer	3.84e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—JAK2—prostate cancer	3.83e-05	0.000232	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1R—prostate cancer	3.83e-05	0.000232	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	3.81e-05	0.000231	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—JAK2—prostate cancer	3.79e-05	0.00023	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LPL—prostate cancer	3.72e-05	0.000226	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LPL—prostate cancer	3.71e-05	0.000225	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—IL2—prostate cancer	3.69e-05	0.000224	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PDGFRB—prostate cancer	3.69e-05	0.000224	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CAV1—prostate cancer	3.68e-05	0.000223	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—IL2—prostate cancer	3.68e-05	0.000223	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PDGFRB—prostate cancer	3.68e-05	0.000223	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LPL—prostate cancer	3.67e-05	0.000223	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CB—prostate cancer	3.65e-05	0.000221	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—IL2—prostate cancer	3.64e-05	0.000221	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	3.64e-05	0.000221	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CB—prostate cancer	3.64e-05	0.000221	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	3.6e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ITGB3—prostate cancer	3.59e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ITGB3—prostate cancer	3.58e-05	0.000217	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ITGB3—prostate cancer	3.55e-05	0.000215	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	3.51e-05	0.000213	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CXCL8—prostate cancer	3.5e-05	0.000212	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ERBB3—prostate cancer	3.49e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGFR2—prostate cancer	3.48e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ERBB3—prostate cancer	3.47e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGFR2—prostate cancer	3.47e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	3.46e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ERBB3—prostate cancer	3.44e-05	0.000209	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGFR2—prostate cancer	3.44e-05	0.000208	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CG—prostate cancer	3.36e-05	0.000203	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL2—prostate cancer	3.35e-05	0.000203	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL2—prostate cancer	3.34e-05	0.000203	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TERT—prostate cancer	3.34e-05	0.000203	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TERT—prostate cancer	3.33e-05	0.000202	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL2—prostate cancer	3.31e-05	0.000201	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TERT—prostate cancer	3.3e-05	0.0002	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HIF1A—prostate cancer	3.19e-05	0.000194	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HIF1A—prostate cancer	3.18e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—INS—prostate cancer	3.18e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HIF1A—prostate cancer	3.15e-05	0.000191	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LEP—prostate cancer	3.12e-05	0.000189	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CREBBP—prostate cancer	3.11e-05	0.000189	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LEP—prostate cancer	3.11e-05	0.000188	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CAV1—prostate cancer	3.09e-05	0.000187	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CAV1—prostate cancer	3.08e-05	0.000187	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LEP—prostate cancer	3.08e-05	0.000187	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KDR—prostate cancer	3.06e-05	0.000185	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CAV1—prostate cancer	3.05e-05	0.000185	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KDR—prostate cancer	3.05e-05	0.000185	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KDR—prostate cancer	3.02e-05	0.000183	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ESR1—prostate cancer	2.98e-05	0.000181	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ESR1—prostate cancer	2.97e-05	0.00018	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CD—prostate cancer	2.95e-05	0.000179	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ESR1—prostate cancer	2.94e-05	0.000178	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—BAD—prostate cancer	2.91e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—BAD—prostate cancer	2.9e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—BAD—prostate cancer	2.87e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APC—prostate cancer	2.81e-05	0.000171	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	2.81e-05	0.000171	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APC—prostate cancer	2.81e-05	0.00017	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	2.81e-05	0.00017	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—NOS3—prostate cancer	2.79e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IRS1—prostate cancer	2.78e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGF—prostate cancer	2.78e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APC—prostate cancer	2.78e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	2.78e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IRS1—prostate cancer	2.77e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGF—prostate cancer	2.77e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IRS1—prostate cancer	2.75e-05	0.000166	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGF—prostate cancer	2.75e-05	0.000166	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GSK3B—prostate cancer	2.7e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GSK3B—prostate cancer	2.69e-05	0.000163	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GSK3B—prostate cancer	2.67e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—INS—prostate cancer	2.66e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—INS—prostate cancer	2.66e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—INS—prostate cancer	2.63e-05	0.000159	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CREBBP—prostate cancer	2.61e-05	0.000158	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CREBBP—prostate cancer	2.6e-05	0.000158	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1—prostate cancer	2.58e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CREBBP—prostate cancer	2.58e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CB—prostate cancer	2.57e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1—prostate cancer	2.57e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—EGFR—prostate cancer	2.56e-05	0.000155	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—EGFR—prostate cancer	2.56e-05	0.000155	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—prostate cancer	2.55e-05	0.000154	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1—prostate cancer	2.54e-05	0.000154	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—EGFR—prostate cancer	2.53e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	2.49e-05	0.000151	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	2.48e-05	0.000151	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	2.47e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	2.47e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	2.46e-05	0.000149	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	2.45e-05	0.000149	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	2.45e-05	0.000148	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	2.44e-05	0.000148	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	2.44e-05	0.000148	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	2.44e-05	0.000148	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—KRAS—prostate cancer	2.42e-05	0.000147	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	2.42e-05	0.000147	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	2.42e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—KRAS—prostate cancer	2.41e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—KRAS—prostate cancer	2.39e-05	0.000145	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF2—prostate cancer	2.37e-05	0.000144	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF2—prostate cancer	2.36e-05	0.000143	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF2—prostate cancer	2.34e-05	0.000142	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOS3—prostate cancer	2.34e-05	0.000142	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOS3—prostate cancer	2.33e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOS3—prostate cancer	2.31e-05	0.00014	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JAK2—prostate cancer	2.27e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JAK2—prostate cancer	2.26e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JAK2—prostate cancer	2.24e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	2.23e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTEN—prostate cancer	2.22e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	2.22e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MDM2—prostate cancer	2.22e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MDM2—prostate cancer	2.21e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	2.2e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MDM2—prostate cancer	2.19e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ERBB2—prostate cancer	2.19e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ERBB2—prostate cancer	2.18e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ERBB2—prostate cancer	2.16e-05	0.000131	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	2.16e-05	0.000131	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	2.15e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	2.13e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—EP300—prostate cancer	2.12e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL8—prostate cancer	2.07e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL8—prostate cancer	2.07e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL8—prostate cancer	2.05e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	2.02e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	2.02e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	2e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	2e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	2e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASP3—prostate cancer	1.98e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL2—prostate cancer	1.98e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASP3—prostate cancer	1.98e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.98e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL2—prostate cancer	1.97e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6—prostate cancer	1.97e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6—prostate cancer	1.96e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.96e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL2—prostate cancer	1.96e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.95e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCND1—prostate cancer	1.93e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCND1—prostate cancer	1.92e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	1.91e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	1.91e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCND1—prostate cancer	1.91e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.89e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—prostate cancer	1.87e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—prostate cancer	1.87e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	1.87e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTEN—prostate cancer	1.86e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	1.86e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTEN—prostate cancer	1.86e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.85e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.84e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.84e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—prostate cancer	1.82e-05	0.00011	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—prostate cancer	1.81e-05	0.00011	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.79e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EP300—prostate cancer	1.78e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EP300—prostate cancer	1.77e-05	0.000107	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EP300—prostate cancer	1.75e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SRC—prostate cancer	1.73e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SRC—prostate cancer	1.72e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SRC—prostate cancer	1.71e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—prostate cancer	1.68e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—prostate cancer	1.68e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT3—prostate cancer	1.67e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.66e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT3—prostate cancer	1.66e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.65e-05	9.97e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CA—prostate cancer	1.57e-05	9.5e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MYC—prostate cancer	1.55e-05	9.39e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFB1—prostate cancer	1.55e-05	9.37e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MYC—prostate cancer	1.54e-05	9.36e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFB1—prostate cancer	1.54e-05	9.34e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MYC—prostate cancer	1.53e-05	9.27e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.53e-05	9.25e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGFR—prostate cancer	1.51e-05	9.18e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGFR—prostate cancer	1.51e-05	9.15e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.5e-05	9.07e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KRAS—prostate cancer	1.43e-05	8.68e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KRAS—prostate cancer	1.43e-05	8.65e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KRAS—prostate cancer	1.41e-05	8.56e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	1.31e-05	7.97e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	1.31e-05	7.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	1.3e-05	7.87e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—prostate cancer	1.28e-05	7.76e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TP53—prostate cancer	1.27e-05	7.71e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TP53—prostate cancer	1.27e-05	7.69e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TP53—prostate cancer	1.26e-05	7.61e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6—prostate cancer	1.16e-05	7.06e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6—prostate cancer	1.16e-05	7.04e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6—prostate cancer	1.15e-05	6.97e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—prostate cancer	1.07e-05	6.51e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—prostate cancer	1.07e-05	6.49e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—prostate cancer	1.06e-05	6.43e-05	CbGpPWpGaD
